Trial Profile
A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jun 2020
Price :
$35
*
At a glance
- Drugs Beraprost (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions
- Sponsors Lung Rx
- 17 Jun 2014 New trial record